Residual Solvent Analysis in Pharmaceuticals

The author discusses the current pharmacopeial status of the acceptance limits and classifications of pharmaceutical residual solvents.

External Link - article-38267.pdf

Articles in this issue

almost 24 years ago

Article

Contract Services

almost 24 years ago

Article

Major Changes Ahead for FDA

almost 24 years ago

Article

Estimation of Distribution Coefficients from the Partition Coefficient and pKa

almost 24 years ago

Article

Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Residual Solvent Analysis in Pharmaceuticals

Articles in this issue

Trending on Pharmaceutical Technology

Pharma's Next AI Problem Is Authority

What to Know from the FDA’s End of August Activity

Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines

From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk

Rethinking the Path from Spray-Dried Dispersions to Tablets: The Role of Continuous Direct Compression